Trial Profile
Assessing the Effect of Contraception and the Menstrual Cycle on Pharmacokinetics, Pharmacodynamics, and Vaginal Safety in Tenofovir Vaginal Gel Users
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Aug 2020
Price :
$35
*
At a glance
- Drugs Tenofovir (Primary) ; Ethinylestradiol/levonorgestrel; Medroxyprogesterone
- Indications HIV infections
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors CONRAD
- 11 Sep 2018 Results published in the JAIDS
- 09 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 11 Dec 2013 Planned end date changed from 1 Oct 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov record.